BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37195263)

  • 21. hRAD30 mutations in the variant form of xeroderma pigmentosum.
    Johnson RE; Kondratick CM; Prakash S; Prakash L
    Science; 1999 Jul; 285(5425):263-5. PubMed ID: 10398605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
    Magnaldo T; Sarasin A
    Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
    Lambert WC; Lambert MW
    Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin cancer and chromosomal aberrations induced by ultraviolet radiation. Evidence for lack of correlation in xeroderma pigmentosum variant and group E patients.
    Seguin LR; Ganges MB; Tarone RE; Robbins JH
    Cancer Genet Cytogenet; 1992 Jun; 60(2):111-6. PubMed ID: 1606553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal, error-prone bypass of photoproducts by xeroderma pigmentosum variant cell extracts results in extreme strand bias for the kinds of mutations induced by UV light.
    McGregor WG; Wei D; Maher VM; McCormick JJ
    Mol Cell Biol; 1999 Jan; 19(1):147-54. PubMed ID: 9858539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
    Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
    Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translesion replication in cisplatin-treated xeroderma pigmentosum variant cells is also caffeine-sensitive: features of the error-prone DNA polymerase(s) involved in UV-mutagenesis.
    Yamada K; Takezawa J; Ezaki O
    DNA Repair (Amst); 2003 Aug; 2(8):909-24. PubMed ID: 12893087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
    Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N
    J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
    Sugasawa K
    Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts.
    Wang YC; Maher VM; Mitchell DL; McCormick JJ
    Mol Cell Biol; 1993 Jul; 13(7):4276-83. PubMed ID: 8321229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spotlight on 'xeroderma pigmentosum'.
    Fassihi H
    Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient repair of cyclobutane pyrimidine dimers at mutational hot spots is restored in complemented Xeroderma pigmentosum group C and trichothiodystrophy/xeroderma pigmentosum group D cells.
    Zhou NY; Bates SE; Bouziane M; Stary A; Sarasin A; O'Connor TR
    J Mol Biol; 2003 Sep; 332(2):337-51. PubMed ID: 12948486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UV-induced mutations in epidermal cells of mice defective in DNA polymerase η and/or ι.
    Kanao R; Yokoi M; Ohkumo T; Sakurai Y; Dotsu K; Kura S; Nakatsu Y; Tsuzuki T; Masutani C; Hanaoka F
    DNA Repair (Amst); 2015 May; 29():139-46. PubMed ID: 25733082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shining a light on xeroderma pigmentosum.
    DiGiovanna JJ; Kraemer KH
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide.
    Latancia MT; Moreno NC; Leandro GS; Ribeiro VC; de Souza I; Vieira WKM; Bastos AU; Hoch NC; Rocha CRR; Menck CFM
    Mutat Res Genet Toxicol Environ Mutagen; 2022 Jun; 878():503498. PubMed ID: 35649682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
    Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
    J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.